ArticleCancers2022

Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study.

Stefano Granieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.